Alvotech (ALVO) Net Income (2021 - 2026)
Alvotech (ALVO) posted Net Income of $123000.0 for Q1 2026, down 99.96% on a QoQ basis from $299.9 million in Q4 2025, and down 99.9% year-over-year from $126.2 million in Q1 2025.
Alvotech (ALVO) Net Income (2021 - 2026) Analysis & Trends
Alvotech's Net Income history runs 6 years deep, the most recent figure standing at $123000.0 for Q1 2026.
- Quarterly Net Income fell 99.9% year-over-year to $123000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50.1 million (up 196.65% YoY) and the FY2025 annual result came in at $27.9 million, up 111.31% from the prior year.
- Net Income was $123000.0 for Q1 2026 at Alvotech, down from $299.9 million in the prior quarter.
- Across five years, Net Income topped out at $372.2 million in Q2 2024 and bottomed at -$551.7 million in Q4 2023.
- A 5-year average of -$75.6 million and a median of -$86.9 million in 2023 frame the typical range for Net Income.
- Annual changes were most pronounced in 2022 — Net Income tumbled 302.39% — and 2025, when it soared 229.34%.
- Alvotech's Net Income stood at -$513.6 million in 2022, then slipped by 7.43% to -$551.7 million in 2023, then soared by 57.98% to -$231.9 million in 2024, then surged by 229.34% to $299.9 million in 2025, then sank by 99.96% to $123000.0 in 2026.
- Business Quant data shows ALVO's Net Income at $123000.0 in Q1 2026, $299.9 million in Q4 2025, and -$307.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | 123,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 123,000.00 |
| Dec 31, 2025 | 299.90 Mn |
| Sep 30, 2025 | -307.87 Mn |
| Jun 30, 2025 | 57.96 Mn |
| Mar 31, 2025 | 126.18 Mn |
| Dec 31, 2024 | -231.86 Mn |
| Sep 30, 2024 | -318.40 Mn |
| Jun 30, 2024 | 372.23 Mn |
| Mar 31, 2024 | -218.73 Mn |
| Dec 31, 2023 | -551.73 Mn |
| Aug 31, 2023 | -86.85 Mn |
| Jun 30, 2023 | 363.03 Mn |
| Mar 31, 2023 | -276.18 Mn |
| Dec 31, 2022 | -513.58 Mn |
| Aug 31, 2022 | -184.47 Mn |
| Jun 30, 2022 | 261.45 Mn |
| Mar 31, 2022 | -76.98 Mn |
| Dec 31, 2021 | 253.76 Mn |
| Sep 30, 2021 | -81.32 Mn |